Seyed Zaidi
Cardiovascular Disease · Sugar Land, TXNPI 1114456530
Payments from drug & device makers
Across 322 payments — averaging $59.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$11K
- Boston Scientific$3K
- Shockwave Medical, Inc$1K
- Abbott$1K
- Abiomed$700
- Cvrx, Inc.$667
- plus $2K from 18 others
What the payments were for
- Grants$1,1266%
- Travel & lodging$6103%
- Food & beverage$17,42891%
- Education$670%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 219 | $10,906 |
| Boston Scientific | 23 | $2,715 |
| Shockwave Medical, Inc | 11 | $1,222 |
| Abbott | 14 | $1,020 |
| Abiomed | 8 | $700 |
| Cvrx, Inc. | 5 | $667 |
| Heartflow, Inc. | 2 | $371 |
| Medtronic | 9 | $371 |
| Johnson & Johnson | 10 | $365 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $227 |
| Scpharmaceuticals Inc. | 1 | $140 |
| Cordis US CORP. | 1 | $102 |
| Cathworks, Inc. | 1 | $84 |
| Philips North America LLC | 3 | $79 |
| Penumbra, Inc. | 1 | $63 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Impulse Dynamics (USA) Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Amgen | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Teleflex LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$1,273
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$919
- EVOQUE$654
- Edwards SAPIEN 3 Transcatheter Heart Valve$579
- Barostim Neo System$518
- PASCAL$399
- FFRct$371
- Impella$290
- OPTIS$267
- Emerge Push$263
- WATCHMAN FLX$172
- CARDIOMEMS$163
- CROSSBOSS$158
- FUROSCIX$140
- 3F$137
- XARELTO$125
- Sentinel$121
- COREVALVE EVOLUT R$119
- Rotablator Rotational Atherectomy System Console Kit$119
- MYNX CONTROL$102
How this compares
$19,232 in reported general payments places this provider in the 80th percentile of 1,515 cardiovascular disease providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 79 | $1,019 |
| Metoprolol Succinate | 14 | $306 |
| Atorvastatin Calcium | 17 | $75 |
| Furosemide | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Sugar Land
- Ramin Farzaneh-FarDallas$17.1M
- Jeffrey GladdenDallas$15.8M
- Ann NavarDallas$14.5M
- David BrabhamAmarillo$11.5M
- Justin GrodinDallas$6.2M
- Christie BallantyneHouston$4.6M
- Syed NaqviHouston$3.6M
- Faisal WahidMcKinney$3.4M
- James FeldmanHouston$3.1M
- Fernando BoccalandroOdessa$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.